account_balance
Investment manager · 13F filer · SEC CIK 1627608
Monashee Investment Management LLC
Reported value$33.4Mas of Sep 30, 2026
Positions16 13 new, 20 sold out
Top 10 weight88.4%Axon Enterprise Inc alone is 15%
FiledNov 637 days after quarter end
Portfolio · as of Sep 30, 2026
Where the money is
New or addedTrimmedHeld
Axon Enterprise Inc
14.8%New
IMMXImmix Biopharma Inc
14.0%New
SYYSysco Corp
12.8%New
NWCLNewcleo PLC
9.4%New
ADTAdt Inc
9.1%Trimmed −17%
SLDBSolid Biosciences Inc
8.9%Trimmed −18%
ENBEnbridge Inc
7.0%New
Viking Therapeutics Inc
4.6%New
BLSMBlossomhill Therapeutics Inc
4.5%New
ETRA3.4%YARWYarrow Bioscience Inc
2.7%New
IMAImagenebio Inc
2.4%Trimmed −8%
Axon Enterprise Inc
14.8%New
IMMXImmix Biopharma Inc
14.0%New
SYY12.8%NWCL9.4%ADT9.1%SLDB8.9%ENB7.0%Viking Therapeutics Inc4.6%
BLSM4.5%ETRA3.4%YARWIMABoxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
Axon Enterprise Inc 14.8% New
IMMX Immix Biopharma Inc 14.0% NewSYY Sysco Corp 12.8% NewNWCL Newcleo PLC 9.4% NewADT Adt Inc 9.1% Trimmed −17%SLDB Solid Biosciences Inc 8.9% Trimmed −18%ENB Enbridge Inc 7.0% NewViking Therapeutics Inc 4.6% New
BLSM Blossomhill Therapeutics Inc 4.5% NewETRA Electra Therapeutics Inc 3.4% NewYARW Yarrow Bioscience Inc 2.7% NewIMA Imagenebio Inc 2.4% Trimmed −8%What changed